Abstract:Objective To prepare and express the Rta recombinant antigen of Epstein-Barr virus and to establish an ELISA method in order to facilitate the screening of nasopharyngeal carcinoma (NPC).Methods The target gene BRLF1 which coded for Rta was ampliflied by PCR with a specific primer. The recombinant vector pPICZαA-BRLF1 was electronically transformed into pichia pastoris GS115 to express Rta protein so as to screen the His+Mut+ phenotype transformant before proteins were purified and the immunogenicity of the product was proved by Western blot. ELISA was established with the IgG/Rta antibody and was applied to the detection of 300 patients with NPC and 200 healthy people to assess the capability of detection.Results The pPICZαA-BRLF1 recombinant plasmid was successfully constructed and the target protein was secreted and expressed with high-performance (50%). Protein electrophoresis demonstrated a corresponding band in 66 KDa. Western blot showed a good immune-competence with the IgG monoclonal antibody of Rta. The Rta recombinant antigen was used for establishment of the ELISA method. The positive rate of this method was significantly higher than that of IgA/VCA Kit for screening NPC (P<0.01). Conclusion A eukaryotic expression vector of the Rta recombinant antigen of Epstein-Barr virus has been constructed that can ensure the high-performance of foreign proteins with good immunogenicity for the development of IgG/Rta ELISA methods. The detection capability can be improved by combining other antigens and this method is applicable to large-scale screening and diagnosis of NPC.
郑凤娇, 傅泳航, 陈文思①, 刘 楠②*. EB病毒重组抗原Rta蛋白的表达及用于鼻咽癌筛查ELISA方法的建立[J]. 解放军预防医学杂志, 2016, 34(4): 464-467.
ZHENG Fengjiao, FU Yonghang, CHEN Wensi, LIU Nan. Expression of Rta Recombinant Antigen of Epstein-Barr Virus and Establishment of ELISA Method for Nasopharyngeal Carcinoma Screening. Journal of Preventive Medicine of Chinese People's Liberation Army, 2016, 34(4): 464-467.
(1) 连仕锋,季明芳,吴标华,等.EB病毒血清学筛查鼻咽癌高、中危人群的随访研究(J).中华预防医学杂志,2015,49(1):26. (2) NYSTAD T,MYRMEL H.Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-,VCA IgM-and EBNA-1-antibodies and suspected infectious mononucleosis(J).Journal of Clinical Virology,2007,38(4):292. (3) FENG P,CHAN S H,OACHELSOO M Y,et al.Antibody response to Epstein-Barr virus Rta protein in patients with nasopharngeal carcinoma(J).Cancer,2001,92(7):1872. (4) HORI K,OKANO S,SATO F.Efficient microbial production of stylopine using a Pichia pastoris expression system(J).Scientific Reports,2016,6:22201. (5) YE Q,Sun Y,WU Y,et al.Pichia pastoris production of Tat-NGB and its neuroprotection on rat pheochromocytoma cells(J).Molecular Biotechnology,2016,58(1):22. (6) VICI,A C,da CRUZ A F,FACCHINI F D,et al.Beauveria bassiana lipase A expressed in Komagataella (Pichia) pastoris with potential for biodiesel catalysis(J).Frontiers in Microbiology,2015,6:1083. (7) ZHOU Y,FAN Y,LAPATRA S E,et al.Protective immunity of a Pichia pastoris expressed recombinant iridovirus major capsid protein in the Chinese giant salamander,Andrias davidianus(J).Vaccine,2015,33(42):5662. (8) ZHANG X,LIU J,YU X.High-level expression of human arginase I in Pichia pastoris and its immobilization on chitosan to produce L-ornithine(J). BMC Biotechnology,2015,15:66. (9) CAPONE S,HORVAT J,HERWIG C,et al.Development of a mixed feed strategy for a recombinant Pichia pastoris strain producing with a de-repression promoter(J).Microbial Cell Factories.2015,14:101. (10) MACAULEY-PATRICK S,FAZENDA ML,MCNEIL B,et al.Heterologous protein production using the Pichia pastoris expression system(J).Yeast,2005,22(4):249. (11) 王莎,唱韶红,刘波,等.H7N9流感病毒血凝素HA在毕赤酵母中的表达及免疫原性分析(J).军事医学,2015,39(6):448. (12) LENASSI Z,TROBEC S,GABERC-POREKAR V,et al.High expression of green fluorescent protein in Pichis pastoris leads to formation of fluorescent particles(J).Journal of Biotechnology,2004,109(1-2):115. (13) 伊强,王文华,陈丹,等.以合成肽为抗原建立ELISA试验检测鼻咽癌患者EB病毒抗体的研究(J).中华肿瘤防治杂志,2008,15(8):610. (14) 张晓梅,钟建明,汤敏中.EBV4型IgA/VCA、IgA/EA、IgG/EA IgG/ZEBRA抗体在鼻咽癌普查和早期诊断中的应用(J).中华实验和临床病毒学杂志,2006,20(3):263. (15) EB病毒Rta蛋白抗体IgG联合两种抗体在鼻咽癌诊断和筛查中的应用价值(J).检验医学与临床,2013,10(3):321.